» Authors » Shinsuke Nagasawa

Shinsuke Nagasawa

Explore the profile of Shinsuke Nagasawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 71
Citations 194
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Komori K, Yamada T, Ando S, Nagasawa S, Kanematsu K, Morita J, et al.
Anticancer Res . 2025 Mar; 45(3):1205-1214. PMID: 40037862
Background/aim: Neoadjuvant chemotherapy is gaining recognition for its potential to improve survival outcomes, with combined neoadjuvant and adjuvant therapies under investigation. However, the prognostic significance of post-chemotherapy pathological staging (ypStage)...
2.
Yamada T, Nagasawa S, Kanematsu K, Morita J, Onuma S, Tanabe M, et al.
Asian J Endosc Surg . 2024 Dec; 18(1):e70014. PMID: 39739847
Introduction: Laparoscopic distal gastrectomy (LDG) is the standard treatment for gastric cancer, during which the laparoscopic Billroth I anastomosis technique, also known as the delta-shaped anastomosis (DA), is widely performed....
3.
Kanematsu K, Nakayama Y, Tanabe M, Morita J, Nagasawa S, Yamada T, et al.
Gastric Cancer . 2024 Dec; 28(2):275-282. PMID: 39724453
Background: Identifying the most effective postoperative surveillance interval in patients with gastric cancer (GC) remains challenging. To elucidate a logical and effective surveillance schedule, we analyzed GC recurrence risk trends...
4.
Hashimoto I, Komori K, Onuma S, Watanabe H, Suematsu H, Nagasawa S, et al.
World J Surg . 2024 Nov; 49(2):472-482. PMID: 39542839
Background: The postoperative impact of short-term changes in skeletal muscle loss (SML) and adipose tissue loss (ATL) on treatment outcomes is unclear in patients with gastric cancer (GC). We investigate...
5.
Nagasawa S, Akiyama H, Tanabe M, Nakayama Y, Onuma S, Morita J, et al.
In Vivo . 2024 Oct; 38(6):2897-2903. PMID: 39477381
Background/aim: Post-gastrectomy lean body mass (LBM) decrease has a significant negative impact on postoperative survival in patients with cancer. This study investigated the effect of intake of at least one-third...
6.
Oshima T, Hashimoto I, Hiroshima Y, Kimura Y, Tanabe M, Nakayama Y, et al.
Anticancer Res . 2024 Sep; 44(10):4537-4542. PMID: 39348967
Background/aim: Granzyme B (GZMB) is mainly produced by natural killer (NK) cells and activated CD8-positive T cells to induce tumor cell apoptosis. We analyzed the significance of GZMB expression in...
7.
Oshima T, Hashimoto I, Hiroshima Y, Kimura Y, Tanabe M, Nakayama Y, et al.
Anticancer Res . 2024 Sep; 44(10):4579-4584. PMID: 39348954
Background/aim: The function of the S-100 protein family member hornerin (HRNR) in gastric cancer (GC) tissues is largely unknown. We researched the clinical significance of HRNR expression in GC tissues...
8.
Hashimoto I, Nakayama Y, Tanabe M, Morita J, Nagasawa S, Maezawa Y, et al.
Anticancer Res . 2024 Aug; 44(9):3995-4001. PMID: 39197888
Background/aim: The Inflammatory Burden Index (IBI) has been reported as a novel prognostic indicator in several cancers and diseases. However, research on the IBI in patients with gastric cancer (GC)...
9.
Hashimoto I, Komori K, Maezawa Y, Nagasawa S, Kawabe T, Aoyama T, et al.
Oncol Lett . 2024 Aug; 28(4):458. PMID: 39114573
The association of computed tomography (CT)-derived skeletal muscle index (SMI) and skeletal muscle radiodensity (SMD) with postoperative prognosis in patients with gastric cancer (GC) remains unknown. Therefore, the present study...
10.
Hashimoto I, Komori K, Onuma S, Watanabe H, Suematsu H, Nagasawa S, et al.
Anticancer Res . 2024 Jul; 44(8):3515-3524. PMID: 39060072
Background/aim: The sex-specific effect of the visceral-to-subcutaneous fat ratio (VSR) before gastrectomy on postoperative survival in patients with gastric cancer (GC) remains unclear. This study measured the preoperative VSR in...